Evelo Biosciences Target of Unusually Large Options Trading (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of unusually large options trading on Wednesday. Investors bought 1,885 put options on the company. This is an increase of 1,101% compared to the typical daily volume of 157 put options.

Evelo Biosciences Stock Performance

The business has a 50 day moving average price of $0.03 and a two-hundred day moving average price of $0.04. Evelo Biosciences has a one year low of $0.00 and a one year high of $13.93. The stock has a market capitalization of $2,000.00, a P/E ratio of 0.00 and a beta of 1.58.

Institutional Investors Weigh In On Evelo Biosciences

An institutional investor recently raised its position in Evelo Biosciences stock. Vanguard Group Inc. lifted its position in shares of Evelo Biosciences, Inc. (NASDAQ:EVLO) by 129.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 357,711 shares of the company’s stock after purchasing an additional 201,815 shares during the period. Vanguard Group Inc. owned 1.88% of Evelo Biosciences worth $1,402,000 as of its most recent SEC filing. 0.31% of the stock is owned by institutional investors and hedge funds.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.